Presenilins, Deranged Calcium Homeostasis, Synaptic Loss and Dysfunction in Alzheimer's Disease

Alzheimer’s disease (AD) is the most common age-related neurodegenerative disorder affecting millions of people. Synaptic dysfunction and physical loss of synapses are responsible for memory impairments in AD. The molecular mechanisms responsible for synaptic loss in AD are not understood. The main risk factor for sporadic AD (SAD) is advanced age. Missense mutations in presenilin (PS) proteins and in amyloid precursor protein (APP) are responsible for majority of rare familial AD (FAD) cases. Increased production of A 42 amyloidogenic peptide occurs in SAD and FAD. Synaptotoxic effects of A 42 may be linked to synaptic loss in AD. FAD mutations in PS proteins disrupt endoplasmic reticulum (ER) calcium (Ca2+) leak function of PSs and result in increased Ca2+ levels in neuronal ER. Similar increases in neuronal ER Ca2+ levels occur in aging neurons. Increased neuronal ER Ca2+ levels lead to a compensatory upregulation of ER Ca2+ release channels, the ryanodine receptors (RyanR), and downregulation of the synaptic store-operated Ca2+ entry (SOC) pathway. In this review we propose a hypothesis that excessive Ca2+ release from the ER and insufficient SOC Ca2+ entry lead to destabilization and eventual elimination of mature mushroom spines in PS-FAD neurons and in aging SAD neurons. The proposed Ca2+-dependent spine destabilization mechanism may act in parallel or synergistically with A 42 synaptotoxicity mechanisms. The proposed model may help to establish a cause-and-effect connection between abnormal Ca2+ and amyloid homeostasis and synaptic loss in AD.

[1]  Jae Woong Lee,et al.  PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Phillip B. Jones,et al.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. , 2007, The American journal of pathology.

[3]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[4]  W. Klein,et al.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  C. Epstein,et al.  Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. , 2005, Mammalian genome : official journal of the International Mammalian Genome Society.

[6]  John Hardy,et al.  The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.

[7]  E. Godaux,et al.  Mutant Presenilins Disturb Neuronal Calcium Homeostasis in the Brain of Transgenic Mice, Decreasing the Threshold for Excitotoxicity and Facilitating Long-term Potentiation* , 2001, The Journal of Biological Chemistry.

[8]  R. Nicoll,et al.  Expression Mechanisms Underlying NMDA Receptor‐Dependent Long‐Term Potentiation , 1999, Annals of the New York Academy of Sciences.

[9]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[10]  J. Herms,et al.  Role of presenilin1 in structural plasticity of cortical dendritic spines in vivo , 2011, Journal of neurochemistry.

[11]  Menahem Segal,et al.  Dendritic spines shaped by synaptic activity , 2000, Current Opinion in Neurobiology.

[12]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[13]  V. Nimmrich,et al.  Is Alzheimer's Disease a Result of Presynaptic Failure? - Synaptic Dysfunctions Induced by Oligomeric β-Amyloid , 2009, Reviews in the neurosciences.

[14]  M. Mattson,et al.  Hippocampal Spatial Memory Impairments Caused by the Familial Alzheimer’s Disease-Linked Presenilin 1 M146V Mutation , 2005, Neurodegenerative Diseases.

[15]  G. Turrigiano,et al.  Rapid Synaptic Scaling Induced by Changes in Postsynaptic Firing , 2008, Neuron.

[16]  D. Peterson,et al.  Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice , 2002, The Journal of Neuroscience.

[17]  K. Oka,et al.  Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Selkoe,et al.  Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.

[19]  M. Matsuzaki Factors critical for the plasticity of dendritic spines and memory storage , 2007, Neuroscience Research.

[20]  C. Cotman,et al.  Calcium, membranes, aging, and Alzheimer's disease , 1989 .

[21]  F. Kirchhoff,et al.  Reduced Spine Density in Specific Regions of CA1 Pyramidal Neurons in Two Transgenic Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[22]  I. Bezprozvanny,et al.  Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. , 2010, Journal of Alzheimer's disease : JAD.

[23]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.

[24]  M. Frosch,et al.  Presenilin-Mediated Modulation of Capacitative Calcium Entry , 2000, Neuron.

[25]  H. Kretzschmar,et al.  γ-Secretase Inhibition Reduces Spine Density In Vivo via an Amyloid Precursor Protein-Dependent Pathway , 2009, The Journal of Neuroscience.

[26]  T. Sacktor,et al.  Protein synthesis-dependent formation of protein kinase Mzeta in long- term potentiation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  A. Peters,et al.  The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines. , 1970, The American journal of anatomy.

[28]  Ivan V. Goussakov,et al.  NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice , 2010, The Journal of Neuroscience.

[29]  M. Mattson,et al.  Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.

[30]  A. Alpár,et al.  Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice , 2006, Brain Research.

[31]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[32]  B. de Strooper,et al.  Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. , 2003, Neuron.

[33]  T. Pozzan,et al.  Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia , 2005, Neurobiology of Disease.

[34]  M. Mattson,et al.  Progressive age-related impairment of the late long-term potentiation in Alzheimer's disease presenilin-1 mutant knock-in mice. , 2010, Journal of Alzheimer's disease : JAD.

[35]  F. LaFerla,et al.  Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+ Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice , 2006, The Journal of Neuroscience.

[36]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[37]  C. Cotman,et al.  Alzheimer's Presenilin‐1 Mutation Potentiates Inositol 1,4,5‐Trisphosphate‐Mediated Calcium Signaling in Xenopus , 1999, Journal of neurochemistry.

[38]  T. Südhof,et al.  Presenilins are Essential for Regulating Neurotransmitter Release , 2009, Nature.

[39]  Ivan V. Goussakov,et al.  Deviant Ryanodine Receptor-Mediated Calcium Release Resets Synaptic Homeostasis in Presymptomatic 3xTg-AD Mice , 2009, The Journal of Neuroscience.

[40]  Panteleimon Giannakopoulos,et al.  Pathological substrates of cognitive decline in Alzheimer's disease. , 2009, Frontiers of neurology and neuroscience.

[41]  Jean Mariani,et al.  Age-Dependent Impairment of Spine Morphology and Synaptic Plasticity in Hippocampal CA1 Neurons of a Presenilin 1 Transgenic Mouse Model of Alzheimer's Disease , 2009, The Journal of Neuroscience.

[42]  T. Iwatsubo,et al.  Gain-of-Function Enhancement of IP3 Receptor Modal Gating by Familial Alzheimer’s Disease–Linked Presenilin Mutants in Human Cells and Mouse Neurons , 2010, Science Signaling.

[43]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[44]  Alan Peters,et al.  THE SMALL PYRAMIDAL NEURON OF THE RAT CEREBRAL CORTEX , 1968, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[45]  Phillip B. Jones,et al.  A Reporter of Local Dendritic Translocation Shows Plaque- Related Loss of Neural System Function in APP-Transgenic Mice , 2009, The Journal of Neuroscience.

[46]  M. Berridge Neuronal Calcium Signaling , 1998, Neuron.

[47]  Tara Spires-Jones,et al.  Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation , 2010, The Journal of Neuroscience.

[48]  E. Kandel,et al.  Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. , 1994, Learning & memory.

[49]  Jian Zhou,et al.  Critical role of TRPC6 channels in the formation of excitatory synapses , 2008, Nature Neuroscience.

[50]  C. Cotman,et al.  Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress , 2007, Neurobiology of Disease.

[51]  R. Malinow,et al.  Enhanced Synaptic Potentiation in Transgenic Mice Expressing presenilin 1 Familial Alzheimer's Disease Mutation Is Normalized with a Benzodiazepine , 2000, Neurobiology of Disease.

[52]  M. Mattson,et al.  Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.

[53]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[54]  W. Abraham,et al.  Inhibition of protein synthesis in the dentate gyrus, but not the entorhinal cortex, blocks maintenance of long-term potentiation in rats , 1989, Neuroscience Letters.

[55]  Ilya Bezprozvanny,et al.  Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[56]  William J Ray,et al.  Beyond amyloid: the next generation of Alzheimer's disease therapeutics. , 2007, Molecular interventions.

[57]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[58]  T. Spires,et al.  Neuronal Structure is Altered by Amyloid Plaques , 2004, Reviews in the neurosciences.

[59]  Scott A. Small,et al.  Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis , 2008, Neuron.

[60]  Roberto Malinow,et al.  Amyloid beta from axons and dendrites reduces local spine number and plasticity , 2010, Nature Neuroscience.

[61]  Brian J. Bacskai,et al.  Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.

[62]  L. Schiapparelli,et al.  Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels , 2009, Neurobiology of Disease.

[63]  F. LaFerla,et al.  Enhanced caffeine‐induced Ca2+ release in the 3xTg‐AD mouse model of Alzheimer's disease , 2005, Journal of neurochemistry.

[64]  T. Bliss,et al.  Remodelling of synaptic morphology but unchanged synaptic density during late phase long-term potentiation(ltp): A serial section electron micrograph study in the dentate gyrus in the anaesthetised rat , 2004, Neuroscience.

[65]  I. Bezprozvanny,et al.  The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.

[66]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[67]  Grace E. Stutzmann The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[68]  D. Linden,et al.  Synaptic Transmission and Hippocampal Long-Term Potentiation in Transgenic Mice Expressing FAD-Linked Presenilin 1 , 1999, Neurobiology of Disease.

[69]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[70]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[71]  Z. Khachaturian Introduction and Overview , 1989, Annals of the New York Academy of Sciences.

[72]  P. Somogyi,et al.  NMDA Receptor Content of Synapses in Stratum Radiatum of the Hippocampal CA1 Area , 2000, The Journal of Neuroscience.

[73]  T. Südhof,et al.  Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction , 2010, Journal of neurochemistry.

[74]  L. Mucke,et al.  Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin? , 2010, NeuroMolecular Medicine.

[75]  V. Lee,et al.  Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.

[76]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[77]  B. Strooper,et al.  Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.

[78]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[79]  Y. Goda,et al.  Unraveling Mechanisms of Homeostatic Synaptic Plasticity , 2010, Neuron.

[80]  G. Wenk,et al.  Neuropathologic changes in Alzheimer's disease. , 2003, The Journal of clinical psychiatry.

[81]  K. Svoboda,et al.  Experience-dependent structural synaptic plasticity in the mammalian brain , 2009, Nature Reviews Neuroscience.

[82]  Kristen M Harris,et al.  Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? , 2002, Brain Research Reviews.

[83]  S. B. Kater,et al.  Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. , 1994, Annual review of neuroscience.

[84]  Bernardo L Sabatini,et al.  Anatomical and physiological plasticity of dendritic spines. , 2007, Annual review of neuroscience.

[85]  Ian Parker,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. , 2008, The Journal of general physiology.

[86]  B. de Strooper,et al.  Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons , 1999, The Journal of cell biology.

[87]  J. Bourne,et al.  Balancing structure and function at hippocampal dendritic spines. , 2008, Annual review of neuroscience.

[88]  Mu-ming Poo,et al.  Shrinkage of Dendritic Spines Associated with Long-Term Depression of Hippocampal Synapses , 2004, Neuron.

[89]  Petter Laake,et al.  Different modes of expression of AMPA and NMDA receptors in hippocampal synapses , 1999, Nature Neuroscience.

[90]  K. Svoboda,et al.  Structure and function of dendritic spines. , 2002, Annual review of physiology.

[91]  C. Epstein,et al.  Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouseChromosome 12 , 2005, Mammalian Genome.

[92]  B. Strooper,et al.  Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex , 2003, Neuron.

[93]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[94]  J. Bourne,et al.  Do thin spines learn to be mushroom spines that remember? , 2007, Current Opinion in Neurobiology.

[95]  G. Turrigiano The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses , 2008, Cell.

[96]  F. LaFerla,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production , 2008, The Journal of cell biology.

[97]  E. Godaux,et al.  Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1 , 2008, Neurobiology of Aging.

[98]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[99]  Grace E Stutzmann,et al.  Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability , 2004, The Journal of Neuroscience.

[100]  H. Kretzschmar,et al.  Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein , 2006, The Journal of Neuroscience.

[101]  C. Epstein,et al.  Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome , 2004, The Journal of comparative neurology.

[102]  B. Bergmans,et al.  γ-secretases: from cell biology to therapeutic strategies , 2010, The Lancet Neurology.

[103]  E. Jazin,et al.  Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling , 2006, Neurobiology of Disease.

[104]  J. Herms,et al.  Role of APP for dendritic spine formation and stability , 2011, Experimental Brain Research.

[105]  K. Pratt,et al.  Presenilin 1 Regulates Homeostatic Synaptic Scaling Through Akt Signaling , 2011, Nature Neuroscience.

[106]  P. Andersen,et al.  Long-term potentiation is associated with new excitatory spine synapses on rat dentate granule cells. , 1996, Learning & memory.

[107]  B. de Strooper,et al.  Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. , 2007, The Journal of clinical investigation.

[108]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.